Podcast Episode 49 | Pediatric Cardiac Arrest with Dr. Beth Slomine
There is a growing need for neuropsychologists in an inpatient rehab setting and throughout follow-up care for children who are resuscitated after experiencing a cardiac arrest. Today, we talk with Beth Slomine, Ph.D., ABPP-CN, about the risks and benefits associated with therapeutic hypothermia for these children, and her involvement in the THAPCA multi-site trial.
Podcast Episodes 22-23 | Pediatric Epilepsy – With Dr. Nancy Nussbaum
Part I: https://www.navneuro.com/22 Epilepsy is a broad term used to describe various neurologic conditions that cause seizures. According to the Centers for Disease Control and Prevention (CDC), the U.S. had approximately 3 million adults and 470,000 children with epilepsy in 2015. Children with epilepsy are more likely to report academic difficulties, experience cognitive impairment, and […]
Podcast Episode 48 | Neuropsychology of Human Immunodeficiency Virus (HIV) – With Dr. April Thames
The U.S. has the largest annual incidence of new human immunodeficiency virus (HIV) diagnoses among high-income nations. This is relevant for neuropsychologists because many individuals with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively known as HIV-Associated Neurocognitive Disorder (HAND). In this episode, we talk with April Thames, Ph.D., about cross-cultural considerations […]
Podcast Episode 64 | Spina bifida and hydrocephalus, Christine Koterba
Approximately one in every 2,800 babies are born with spina bifida each year. Spina bifida is related to multiple physical and neurological symptoms including hydrocephalus, which differs from its presentation in older adults. Today, John and Ryan talk with Christine Koterba, Ph.D., ABPP-CN, about spina bifida, hydrocephalus, and how neuropsychologists can contribute to the care […]
Podcast Episode 50 | Non-CNS Cancer and Cognition – With Dr. Mike Parsons
The cognitive consequences of non-central nervous system (non-CNS) cancer and cancer-related treatments did not become the subject of scientific investigation until recently and is still a growing area of research. Contemporary studies have made it clear that neuropsychology is an integral part of the evaluation and care of individuals with cancer. Today we talk with […]
Podcast Episode 52 | The Hierarchical Taxonomy of Psychopathology (HiTOP) – With Dr. Robert Latzman
Our current nosology of psychopathology relies on a categorical model that has notable limitations. For example, this medical model of classifying mental disorders does not account for the significant heterogeneity of symptom presentations across psychopathology. Today, we speak with Robert Latzman, Ph.D., to discuss the Hierarchical Taxonomy of Psychopathology (HiTOP), an alternative nosology that uses […]
Podcast Episode 63 | COVID-19: The Role of Neuropsychology – With Dr. Chaya Fridman
Emerging research suggests that a sizeable portion of individuals hospitalized due to COVID-19 develop cognitive and psychological sequelae. In our conversation with Dr. Chaya Fridman, a board-certified neuropsychologist at Cornell, we discuss the ways that SARS-CoV-2 (the virus that causes COVID-19) may lead to neurocognitive impairment, including both direct effects of the virus and secondary […]
Podcast Episode 62 | Multiple Sclerosis: Cognitive and Emotional Sequelae – with Dr. Peter Arnett
About 50% of individuals with multiple sclerosis (MS) exhibit cognitive deficits in additional to physical symptoms. Depression and fatigue are also common in MS and can be debilitating. Therefore, it is not uncommon for an individual with MS to be referred for neuropsychological evaluation, making it important for neuropsychologists to familiarize themselves with the neurobiological […]
Podcast Episode 20 | The Interplay Between Cerebrovascular Disease and Alzheimer’s Disease – With Dr. Adam Brickman
Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation. Dr. Brickman discusses his research on the presence of biomarkers of cerebrovascular disease (e.g., white matter hyperintensities), which are present in aging and Alzheimer’s disease. Although cerebrovascular disease is traditionally associated with its own unique cognitive […]
Podcast Episode 19 | Redefining Alzheimer’s Disease: Does Cognition Matter? – With Dr. Adam Brickman
The estimated annual cost of healthcare for individuals living with Alzheimer’s disease (AD) or other dementias is almost $300 billion. In addition to this financial burden, the number of adults aged 65 or older is projected to double and it is expected an estimated 10 million of these individuals will develop AD by 2050. Despite […]